42 related articles for article (PubMed ID: 15878160)
1. Secondary acute myelogenous leukemia following treatment with oral etoposide.
Katato K; Flaherty L; Varterasian M
Am J Hematol; 1996 Sep; 53(1):54-5. PubMed ID: 8813107
[No Abstract] [Full Text] [Related]
2. Dexrazoxane-associated risk for secondary malignancies in pediatric Hodgkin's disease: a claim without compelling evidence.
Lipshultz SE; Lipsitz SR; Orav EJ
J Clin Oncol; 2007 Jul; 25(21):3179; author reply 3180. PubMed ID: 17634500
[No Abstract] [Full Text] [Related]
3. Do children have increased susceptibility for developing secondary acute myelogenous leukemia?
Pyatt DW; Hays SM; Cushing CA
Chem Biol Interact; 2005 May; 153-154():223-9. PubMed ID: 15878160
[TBL] [Abstract][Full Text] [Related]
4. Is age an independent risk factor for chemically induced acute myelogenous leukemia in children?
Pyatt DW; Aylward LL; Hays SM
J Toxicol Environ Health B Crit Rev; 2007; 10(5):379-400. PubMed ID: 17687725
[TBL] [Abstract][Full Text] [Related]
5. Secondary acute myelogenous leukemia in patients with retinoblastoma: is chemotherapy a factor?
Gombos DS; Hungerford J; Abramson DH; Kingston J; Chantada G; Dunkel IJ; Antoneli CB; Greenwald M; Haik BG; Leal CA; Medina-Sanson A; Schefler AC; Veerakul G; Wieland R; Bornfeld N; Wilson MW; Yu CB
Ophthalmology; 2007 Jul; 114(7):1378-83. PubMed ID: 17613328
[TBL] [Abstract][Full Text] [Related]
6. The molecular pathogenesis of treatment-induced (secondary) leukemias: foundations for treatment and prevention.
Karp JE; Smith MA
Semin Oncol; 1997 Feb; 24(1):103-13. PubMed ID: 9045296
[TBL] [Abstract][Full Text] [Related]
7. The secondary leukemias: challenges and research directions.
Smith MA; McCaffrey RP; Karp JE
J Natl Cancer Inst; 1996 Apr; 88(7):407-18. PubMed ID: 8618232
[TBL] [Abstract][Full Text] [Related]
8. [Leukemias induced by anticancer chemotherapies].
Harousseau JL
Bull Cancer; 1999 Nov; 86(11):929-38. PubMed ID: 10586109
[TBL] [Abstract][Full Text] [Related]
9. Acquired acute myelogenous leukemia after therapy for acute promyelocytic leukemia with t(15;17): a case report and review of the literature.
Betancourt-García RD; Castro J; Fernández AC; López-Enríquez A; Fradera J; Pacheco E
P R Health Sci J; 2009 Jun; 28(2):146-50. PubMed ID: 19530558
[TBL] [Abstract][Full Text] [Related]
10.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
11.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
12.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
13.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
14.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
15.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
